• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为增强P-糖蛋白(ABCB1)调节剂功效策略的多价性的生化基础:用特定长度间隔物分隔的斯替酰胺同二聚体以更高的功效逆转药物外排。

Biochemical basis of polyvalency as a strategy for enhancing the efficacy of P-glycoprotein (ABCB1) modulators: stipiamide homodimers separated with defined-length spacers reverse drug efflux with greater efficacy.

作者信息

Sauna Zuben E, Andrus Merritt B, Turner Timothy M, Ambudkar Suresh V

机构信息

Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4254, USA.

出版信息

Biochemistry. 2004 Mar 2;43(8):2262-71. doi: 10.1021/bi035965k.

DOI:10.1021/bi035965k
PMID:14979722
Abstract

Human P-glycoprotein (Pgp) is as an ATP-dependent efflux pump for a variety of chemotherapeutic drugs. The aim of this study is to evaluate whether Pgp modulators can be engineered to exhibit high-affinity binding using polyvalency. Five bivalent homodimeric polyenes based on stipiamide linked with polyethylene glycol ethers in the range of 3-50 A were synthesized and quantitatively characterized for their effect on Pgp function. The stipiamide homodimers displaced [(125)I]iodoarylazidoprazoin (IAAP), an analogue of the Pgp substrate prazosin. A minimal spacer of 11 A is necessary for inhibition of IAAP labeling, beyond which there is an inverse correlation between the length of the spacer and the IC(50) for the displacement of IAAP. ATP hydrolysis by Pgp on the other hand is stimulated by the dimers with spacers of up to 22 A, whereas dimers with longer spacers inhibit ATP hydrolysis. Finally, the homodimers reverse Pgp-mediated drug efflux in intact cells overexpressing Pgp, and 11 A is a threshold beyond which the effectiveness of the homodimers increases exponentially and levels off at 33 A. We demonstrate that dimerization and identification of an optimal spacer length increase by 11-fold the affinity of stipiamide, and this is reflected in the efficacy with which Pgp-mediated drug efflux is reversed. These results suggest that polyvalency could be a useful strategy for the development of more potent Pgp modulators.

摘要

人P-糖蛋白(Pgp)是一种依赖ATP的多种化疗药物外排泵。本研究的目的是评估是否可以通过多价性设计Pgp调节剂以表现出高亲和力结合。合成了五种基于 stipiamide 且与聚乙二醇醚连接长度在3至50埃范围内的二价同型二聚体多烯,并对其对Pgp功能的影响进行了定量表征。stipiamide 同型二聚体取代了[(125)I]碘芳基叠氮基普拉唑嗪(IAAP),它是Pgp底物哌唑嗪的类似物。抑制IAAP标记需要11埃的最小间隔,超过此间隔,间隔长度与IAAP取代的IC(50)之间呈负相关。另一方面,Pgp的ATP水解受到间隔长度达22埃的二聚体的刺激,而间隔更长的二聚体则抑制ATP水解。最后,同型二聚体在过表达Pgp的完整细胞中逆转Pgp介导的药物外排,11埃是一个阈值,超过该阈值,同型二聚体的有效性呈指数增加,并在33埃时趋于平稳。我们证明二聚化和确定最佳间隔长度使stipiamide的亲和力提高了11倍,这反映在逆转Pgp介导的药物外排的功效上。这些结果表明,多价性可能是开发更有效的Pgp调节剂的有用策略。

相似文献

1
Biochemical basis of polyvalency as a strategy for enhancing the efficacy of P-glycoprotein (ABCB1) modulators: stipiamide homodimers separated with defined-length spacers reverse drug efflux with greater efficacy.作为增强P-糖蛋白(ABCB1)调节剂功效策略的多价性的生化基础:用特定长度间隔物分隔的斯替酰胺同二聚体以更高的功效逆转药物外排。
Biochemistry. 2004 Mar 2;43(8):2262-71. doi: 10.1021/bi035965k.
2
Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.调节剂诱导的人P-糖蛋白底物与ATP位点之间功能串扰中的干扰。
Biochemistry. 2006 Feb 28;45(8):2739-51. doi: 10.1021/bi0521745.
3
A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.多巴胺受体拮抗剂氟哌噻吨的立体异构体对人类多药转运体的抑制作用存在不同机制,其中单个氨基酸残基起了作用。
Biochemistry. 1999 May 18;38(20):6630-9. doi: 10.1021/bi983038l.
4
Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.人P-糖蛋白连接区的结构灵活性允许ATP水解和药物转运。
Biochemistry. 1998 Sep 29;37(39):13660-73. doi: 10.1021/bi9808823.
5
Biochemical and pharmacological properties of an allosteric modulator site of the human P-glycoprotein (ABCB1).人P-糖蛋白(ABCB1)变构调节位点的生化与药理学特性
Biochem Pharmacol. 2006 Jul 14;72(2):145-55. doi: 10.1016/j.bcp.2006.04.008. Epub 2006 Apr 25.
6
N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.N-乙基马来酰亚胺可增强多药耐药细胞中P-糖蛋白与碘芳基叠氮基哌唑嗪的光亲和标记作用。
Anticancer Res. 1997 Jan-Feb;17(1A):357-64.
7
Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.药物结合和核苷酸水解能力是钒酸盐诱导抑制人P-糖蛋白ATP酶的必要条件。
Biochemistry. 1998 Oct 20;37(42):14981-8. doi: 10.1021/bi980072r.
8
Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.五味子酯甲改变底物相互作用并逆转HepG2-DR细胞中P-糖蛋白介导的多药耐药性。
Biochem Pharmacol. 2006 Sep 28;72(7):824-37. doi: 10.1016/j.bcp.2006.06.036. Epub 2006 Aug 4.
9
Allosteric modulation of the human P-glycoprotein involves conformational changes mimicking catalytic transition intermediates.人P-糖蛋白的变构调节涉及模拟催化过渡中间体的构象变化。
Arch Biochem Biophys. 2006 Jun 1;450(1):100-12. doi: 10.1016/j.abb.2006.02.025. Epub 2006 Mar 15.
10
Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.人类P-糖蛋白中两个不同药物相互作用位点的证据。
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10594-9. doi: 10.1073/pnas.94.20.10594.

引用本文的文献

1
Interaction of a Homologous Series of Amphiphiles with P-glycoprotein in a Membrane Environment-Contributions of Polar and Non-Polar Interactions.膜环境中一系列两亲物与P-糖蛋白的相互作用——极性和非极性相互作用的贡献
Pharmaceutics. 2023 Jan 3;15(1):174. doi: 10.3390/pharmaceutics15010174.
2
The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors.人类ATP结合盒转运蛋白P-糖蛋白和ABCG2在癌症及内源性位点多药耐药中的作用:基于结构的抑制剂药物设计的未来机遇
Cancer Drug Resist. 2021;4(4):784-804. doi: 10.20517/cdr.2021.19. Epub 2021 Aug 4.
3
Potential Tools for Eradicating HIV Reservoirs in the Brain: Development of Trojan Horse Prodrugs for the Inhibition of P-Glycoprotein with Anti-HIV-1 Activity.
用于清除大脑中 HIV 储存库的潜在工具:具有抗 HIV-1 活性的 P-糖蛋白抑制作用的特洛伊木马前药的开发。
J Med Chem. 2020 Mar 12;63(5):2131-2138. doi: 10.1021/acs.jmedchem.9b00779. Epub 2019 Sep 20.
4
Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.二聚异恶唑基-1,4-二氢吡啶在多药耐药转运蛋白上具有增强的结合能力。
Bioorg Med Chem. 2017 Jun 15;25(12):3223-3234. doi: 10.1016/j.bmc.2017.04.008. Epub 2017 Apr 8.
5
The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters.多药转运蛋白Pdr5发现25周年:研究不对称ABC转运蛋白的重要模型
Biochem J. 2015 May 1;467(3):353-63. doi: 10.1042/BJ20150042.
6
Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides.关于P-糖蛋白在阿尔茨海默病Aβ1-42肽清除过程中作用的反向证据。
Cell Stress Chaperones. 2015 May;20(3):421-30. doi: 10.1007/s12192-014-0566-8. Epub 2015 Jan 16.
7
Peptide-chlorambucil conjugates combat pgp-dependent drug efflux.肽-苯丁酸氮芥缀合物可对抗PGP依赖性药物外排。
ACS Med Chem Lett. 2011 Apr 7;2(6):419-23. doi: 10.1021/ml1002663. eCollection 2011 Jun 9.
8
Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.非典型抗精神病药喹硫平的可逆二聚体以增加的结合亲和力和在血脑屏障中的原位抑制 p 糖蛋白介导的外排体外。
ACS Chem Neurosci. 2014 Apr 16;5(4):305-17. doi: 10.1021/cn4002329. Epub 2014 Feb 7.
9
Fluorescent probes of the isoxazole-dihydropyridine scaffold: MDR-1 binding and homology model.异恶唑二氢吡啶骨架的荧光探针:MDR-1 结合和同源模型。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):117-21. doi: 10.1016/j.bmcl.2013.11.068. Epub 2013 Dec 4.
10
Homodimers of the Antiviral Abacavir as Modulators of P-glycoprotein Transport in Cell Culture: Probing Tether Length.抗病毒药物阿巴卡韦的同型二聚体作为细胞培养中P-糖蛋白转运的调节剂:探索连接长度。
Medchemcomm. 2013 Oct;4(10). doi: 10.1039/C3MD00196B.